Fetal Brain Biometry by UltrasoundNCT06544967
Differences Between Male and Femal Fetal Brain Biometry by Ultrasound
An observational study of Fetal Brain Biometry by Ultrasound, run by Sohag University at 1 site in Egypt.
Trial summary
Differences of fetal brain biometry as Biparietal diameter,Head circumference,Transcerebellar diameter, Cavum septum pellucidum as regard to fetal gender by ultrasound Read more about this study
- Who is it for?
- Ages 18 to 40 years, women only
- Conditions the study is for
- Fetal Brain Biometry by Ultrasound
- How many people
- 500 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jun 2024to 1 Jun 2025
- How long will I take part?
- 6 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- Women only
- Adult
Study population: healthy women from 18 to 36 weeks gestation of pregnant cases aged from 18 to 40 years normal body mass index range from 18 to 25
Who may be able to join
- healthy women from 18 to 36 weeks gestation of pregnant cases aged from 18 to 40 years normal body mass index range from 18 to 25
Who cannot join
- Pregnant women with any chronic or systemic disease and fetuses with chromosome anomalies or developmental retardation were not included in the study
Trial locations and contacts
1 site in 1 country.
Allam M Abdelmonem, Professor contact
Egypt1 site, 1 recruiting
- Recruiting
Sohag university hospital
Sohag
Magdy M Amin, Professor, 0934602963, portal@med.sohag.edu.eg
About this study
Official title: Sexual Dimorphism of The Fetal Brain Biometry: An Ultrasound-Based Study
Differences of fetal brain biometry as Biparietal diameter,Head circumference,Transcerebellar diameter, Cavum septum pellucidum as regard to fetal gender by ultrasound
- Conditions
- Fetal Brain Biometry by Ultrasound
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Male fetuses between 18 to 36 weeks | Ultrasound biometry | |
| Female fetuses between 18 to 36 weeks | Ultrasound biometry |
What is being measured
The primary outcome is the main question the study is designed to answer.
Fetal brain biometry
In male and female fetuses
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Aug 2024
- Study start1 Jun 2024
- Primary completion31 Dec 2024 (estimated)
- Study completion1 Jun 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Fetal Brain Biometry by UltrasoundStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 500 participants (estimated)
- Target duration
- 6 Months
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Abdelrhman Fathy Mahmoud, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06544967
- Sponsor's protocol ID
- Soh-Med-24-05-05MD
- Status last verified
- Aug 2024
- First submitted
- 6 Aug 2024
- Last updated
- 9 Aug 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sexual Dimorphism of The Fetal Brain Biometry: An Ultrasound-Based Study
- ClinicalTrials.gov ID
- NCT06544967
- Acronym / sponsor ID
- Soh-Med-24-05-05MD
- Conditions
- Fetal Brain Biometry by Ultrasound
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Jun 2024 (actual)
- Primary completion
- 31 Dec 2024 (estimated)
- Study completion
- 1 Jun 2025 (estimated)
- First posted
- 9 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Differences of fetal brain biometry as Biparietal diameter,Head circumference,Transcerebellar diameter, Cavum septum pellucidum as regard to fetal gender by ultrasound
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 6 Months
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Male fetuses between 18 to 36 weeks | – | –Ultrasound biometry |
| Female fetuses between 18 to 36 weeks | – | –Ultrasound biometry |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- Female only
- Age groups
- Adult
- Study population
- healthy women from 18 to 36 weeks gestation of pregnant cases aged from 18 to 40 years normal body mass index range from 18 to 25
Key inclusion criteria (1 listed)
- healthy women from 18 to 36 weeks gestation of pregnant cases aged from 18 to 40 years normal body mass index range from 18 to 25
Key exclusion criteria (1 listed)
- Pregnant women with any chronic or systemic disease and fetuses with chromosome anomalies or developmental retardation were not included in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Fetal brain biometry
Time frame: 6 months
In male and female fetuses
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Aug 2024.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Allam M Abdelmonem, Professor contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Fetal Brain Biometry by Ultrasound, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Abdelrhman F Mahmoud (01141243928, abdelrahman_fathy_post@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fetal brain biometry (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2024.